Literature DB >> 19740754

Structural insights into the mechanism of the allosteric transitions of Mycobacterium tuberculosis cAMP receptor protein.

Manchi C M Reddy1, Satheesh K Palaninathan1, John B Bruning1, Cory Thurman1, Danielle Smith1, James C Sacchettini2.   

Abstract

The cAMP receptor protein (CRP) from Mycobacterium tuberculosis is a cAMP-responsive global transcriptional regulator, responsible for the regulation of a multitude of diverse proteins. We have determined the crystal structures of the CRP.cAMP and CRP.N(6)-cAMP derivative-bound forms of the enzyme to 2.2- and 2.3 A-resolution, respectively, to investigate cAMP-mediated conformational and structural changes. The allosteric switch from the open, inactive conformation to the closed, active conformation begins with a number of changes in the ligand-binding cavity upon cAMP binding. These subtle structural changes and numerous non-bonding interactions between cAMP, the N-domain residues, and the C-domain helices demonstrate that the N-domain hairpin loop acts as a structural mediator of the allosteric switch. Based on the CRP.N(6)-cAMP crystal structure, binding of N(6)-cAMP with a bulkier methylphenylethyl extension from the N6 atom stabilizes the cAMP-binding domain, N-domain hairpin, and C-terminal domain in a similar manner as that of the CRP.cAMP structure, maintaining structural integrity within the subunits. However, the bulkier N6 extension of N(6)-cAMP (in R conformation) is accommodated only in subunit A with minor changes, whereas in subunit B, the N6 extension is in the S conformation hindering the hinge region of the central helix. As a result, the entire N-domain and the C-domain of subunit B integrated by the cAMP portion of this ligand, together tilt away ( approximately 7 degrees tilt) from central helix C, positioning the helix-turn-helix motif in an unfavorable position for the DNA substrate, asymmetrically. Together, these crystal structures demonstrate the mechanism of action of the cAMP molecule and its role in integrating the active CRP structure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740754      PMCID: PMC2794773          DOI: 10.1074/jbc.M109.041343

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density.

Authors:  D E McRee
Journal:  J Struct Biol       Date:  1999 Apr-May       Impact factor: 2.867

2.  Detection of the protein-protein interaction between cyclic AMP receptor protein and RNA polymerase, by (13)C-carbonyl NMR.

Authors:  T W Lee; H S Won; S H Park; Y Kyogoku; B J Lee
Journal:  J Biochem       Date:  2001-07       Impact factor: 3.387

3.  REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use.

Authors:  Alexei A Vagin; Roberto A Steiner; Andrey A Lebedev; Liz Potterton; Stuart McNicholas; Fei Long; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

Review 4.  Functional versatility in the CRP-FNR superfamily of transcription factors: FNR and FLP.

Authors:  J Green; C Scott; J R Guest
Journal:  Adv Microb Physiol       Date:  2001       Impact factor: 3.517

5.  Use of an arrayed promoter-probe library for the identification of macrophage-regulated genes in Mycobacterium tuberculosis.

Authors:  Russell J Hobson; Alan J A McBride; Karen E Kempsell; Jeremy W Dale
Journal:  Microbiology       Date:  2002-05       Impact factor: 2.777

6.  Stoichiometry and structural effect of the cyclic nucleotide binding to cyclic AMP receptor protein.

Authors:  Hyung-Sik Won; Tae-Woo Lee; Sang-Ho Park; Bong-Jin Lee
Journal:  J Biol Chem       Date:  2002-01-07       Impact factor: 5.157

7.  Kinetic studies of cAMP-induced allosteric changes in cyclic AMP receptor protein from Escherichia coli.

Authors:  J Małecki; A Polit; Z Wasylewski
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 8.  Allosteric regulation of the cAMP receptor protein.

Authors:  J G Harman
Journal:  Biochim Biophys Acta       Date:  2001-05-05

9.  Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation.

Authors:  Claire L Spreadbury; Mark J Pallen; Tim Overton; Marcel A Behr; Serge Mostowy; Stephen Spiro; Stephen J W Busby; Jeffrey A Cole
Journal:  Microbiology       Date:  2005-02       Impact factor: 2.777

10.  A member of the cAMP receptor protein family of transcription regulators in Mycobacterium tuberculosis is required for virulence in mice and controls transcription of the rpfA gene coding for a resuscitation promoting factor.

Authors:  Lisa Rickman; Colin Scott; Debbie M Hunt; Thomas Hutchinson; M Carmen Menéndez; Rachael Whalan; Jason Hinds; M Joseph Colston; Jeffrey Green; Roger S Buxton
Journal:  Mol Microbiol       Date:  2005-06       Impact factor: 3.501

View more
  16 in total

Review 1.  Cyclic AMP signalling in mycobacteria: redirecting the conversation with a common currency.

Authors:  Guangchun Bai; Gwendowlyn S Knapp; Kathleen A McDonough
Journal:  Cell Microbiol       Date:  2010-12-28       Impact factor: 3.715

2.  Crystallization and preliminary X-ray diffraction analysis of D53H mutant Escherichia coli cAMP receptor protein.

Authors:  Jing Huang; Tong Wu; Zheng Guo; Tiantian Lou; Shaoning Yu; Weimin Gong; Chaoneng Ji
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-11-29

3.  Reversible acetylation and inactivation of Mycobacterium tuberculosis acetyl-CoA synthetase is dependent on cAMP.

Authors:  Hua Xu; Subray S Hegde; John S Blanchard
Journal:  Biochemistry       Date:  2011-06-10       Impact factor: 3.162

4.  Novel structural features drive DNA binding properties of Cmr, a CRP family protein in TB complex mycobacteria.

Authors:  Sridevi Ranganathan; Jonah Cheung; Michael Cassidy; Christopher Ginter; Janice D Pata; Kathleen A McDonough
Journal:  Nucleic Acids Res       Date:  2018-01-09       Impact factor: 16.971

5.  Genome-wide identification of in vivo binding sites of GlxR, a cyclic AMP receptor protein-type regulator in Corynebacterium glutamicum.

Authors:  Koichi Toyoda; Haruhiko Teramoto; Masayuki Inui; Hideaki Yukawa
Journal:  J Bacteriol       Date:  2011-06-10       Impact factor: 3.490

6.  Directed evolution of the Escherichia coli cAMP receptor protein at the cAMP pocket.

Authors:  Sanjiva M Gunasekara; Matt N Hicks; Jin Park; Cory L Brooks; Jose Serate; Cameron V Saunders; Simranjeet K Grover; Joy J Goto; Jin-Won Lee; Hwan Youn
Journal:  J Biol Chem       Date:  2015-09-16       Impact factor: 5.157

7.  Dysregulation of serine biosynthesis contributes to the growth defect of a Mycobacterium tuberculosis crp mutant.

Authors:  Guangchun Bai; Damen D Schaak; Eric A Smith; Kathleen A McDonough
Journal:  Mol Microbiol       Date:  2011-09-08       Impact factor: 3.501

8.  Mycobacterium tuberculosis cAMP receptor protein (Rv3676) differs from the Escherichia coli paradigm in its cAMP binding and DNA binding properties and transcription activation properties.

Authors:  Melanie Stapleton; Ihtshamul Haq; Debbie M Hunt; Kristine B Arnvig; Peter J Artymiuk; Roger S Buxton; Jeffrey Green
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

9.  Allosteric mutants show that PrfA activation is dispensable for vacuole escape but required for efficient spread and Listeria survival in vivo.

Authors:  Caroline Deshayes; Magdalena K Bielecka; Robert J Cain; Mariela Scortti; Aitor de las Heras; Zbigniew Pietras; Ben F Luisi; Ricardo Núñez Miguel; José A Vázquez-Boland
Journal:  Mol Microbiol       Date:  2012-06-21       Impact factor: 3.501

10.  Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.

Authors:  Thomas L Rodgers; Philip D Townsend; David Burnell; Matthew L Jones; Shane A Richards; Tom C B McLeish; Ehmke Pohl; Mark R Wilson; Martin J Cann
Journal:  PLoS Biol       Date:  2013-09-10       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.